Ethanol withdrawal induces hyperalgesia mediated by PKCepsilon.

Area of Science:

• Neuroscience
• Pharmacology
• Toxicology

Background:

• Ethanol withdrawal symptoms include sensory hypersensitivity, tremors, and convulsions.
• Alcohol-induced peripheral neuropathy is a significant health concern.
• Previous research showed continuous alcohol intake causes hyperalgesia over 4 weeks.

Purpose of the Study:

• To investigate if repeated cycles of ethanol intake and withdrawal worsen alcohol-induced peripheral neuropathy.
• To determine the conditions under which ethanol withdrawal induces hyperalgesia.
• To explore potential therapeutic targets for withdrawal-induced hyperalgesia.

Main Methods:

• Male rats were fed alcohol (6.5%) in cycles of 4 days on, 3 days off.
• Hyperalgesia was assessed during withdrawal periods.
• The effect of intrathecal antisense oligodeoxynucleotide to protein kinase C epsilon (PKCε) was evaluated.

Main Results:

• Cyclical alcohol exposure induced withdrawal hyperalgesia, peaking by the fourth cycle.
• Hyperalgesia required at least 2 days of ethanol cessation.
• Lower ethanol consumption paradoxically led to faster hyperalgesia development (1.4-1.6% ethanol).
• Continued ethanol exposure showed a neuroprotective effect.
• Intrathecal PKCε inhibition reversed withdrawal-induced hyperalgesia.

Conclusions:

• Repeated ethanol withdrawal episodes exacerbate peripheral neuropathy symptoms.
• Ethanol withdrawal, not just continuous intake, can cause significant hyperalgesia.
• Protein kinase C epsilon (PKCε) is a potential therapeutic target for managing alcohol withdrawal-related pain.